Article

Focus on Liver Cancer (HCC) Care

Author(s):

Donna Cryer

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre & post liver transplant, and liver cancer.

The effects of the novel coronavirus pandemic on liver patients’ ability to access non-COVID-19 related care have been broad and pervasive. The guidance for initiation of treatment and management for patients with viral hepatitis, transplant and cancer have been in flux during this unprecedented time of COVID for several months. In this update, I will focus on information for liver cancer patients and the efforts Global Institute is taking to help to define impactful, long term solutions.

Click here to view the full article.

Related Videos
Related Content
Site Logo
October 3rd 2023

Global Communities Rally around Third Deadliest Cancer – Liver Cancer

Global Liver Institute Leads International Program to Build Hope and Raise Awareness during October, Liver Cancer Awareness Month.
We Need You in The Fight Against Liver Cancer, Join #OctoberIs4Livers 2021
October 13th 2021

We Need You in The Fight Against Liver Cancer, Join #OctoberIs4Livers 2021

The GLI LIVE episode with Dr. Sharpless is the first #OctoberIs4Livers activity in a series of engaging and informative global activities taking place throughout the month of October to raise awareness about liver cancer and address the many disparities that exist with this disease.
Global Liver Institute Applauds FDA and CDC Actions to Approve Third COVID-19 Vaccine Dose for Immunocompromised Individuals
August 13th 2021

Global Liver Institute Applauds FDA and CDC Actions to Approve Third COVID-19 Vaccine Dose for Immunocompromised Individuals

Global Liver Institute (GLI) CEO and President Donna R. Cryer, JD, today applauded dual actions from U.S. government health agencies.
The Need to Support the Restart of Liver Disease Medical Research and Public Health Programs
May 16th 2021

The Need to Support the Restart of Liver Disease Medical Research and Public Health Programs

Donna Cryer
Few liver health advocacy organizations have policy staff or personnel in Washington, DC. To fill this gap, we provide liver health policy updates to report on timely information and actionable updates on activities relevant to liver health, including liver cancer, viral hepatitis, autoimmune liver conditions as well as issues that span conditions, such as coverage or other policy decisions.
More Vaccines, Fewer Tests: Why COVID-19 Testing Remains Important
May 9th 2021

More Vaccines, Fewer Tests: Why COVID-19 Testing Remains Important

Donna Cryer
The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre/post liver transplant and liver cancer.
Scientific Peer Review of Congressionally Directed Medical Research Programs’ Peer Reviewed Cancer Research Program for the Department of Defense
November 16th 2020

Scientific Peer Review of Congressionally Directed Medical Research Programs’ Peer Reviewed Cancer Research Program for the Department of Defense

Donna Cryer
The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate Steven West recently participated in the evaluation of research applications submitted to the PRCRP.